Inhibition of thrombin-induced tissue-type plasminogen activator release by agents which increase intracellular cyclic AMP.
Klöcking
H P
HP
Institute of Pharmacology and Toxicology, Medical Academy Erfurt, GDR.
Hoffmann
A
A
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000527:Alprostadil / Q000494:pharmacology; D000818:Animals; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D004431:Ear, External / Q000378:metabolism; D066298:In Vitro Techniques; D020105:Milrinone; D010477:Perfusion; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D011724:Pyridazines / Q000494:pharmacology; D011728:Pyridones / Q000494:pharmacology; D012996:Solutions; D013552:Swine; D013917:Thrombin / Q000037:antagonists & inhibitors*; D010959:Tissue Plasminogen Activator / Q000378:metabolism*
D010726:Phosphodiesterase Inhibitors; D011724:Pyridazines; D011728:Pyridones; D012996:Solutions; D005576:Colforsin; C051270:motapizone; D000242:Cyclic AMP; D013917:Thrombin; D010959:Tissue Plasminogen Activator; D000527:Alprostadil; D020105:Milrinone; D015056:1-Methyl-3-isobutylxanthine